Trial reportScientific reports2026
Resonance frequency versus fixed 0.1 Hz breathing in HRV biofeedback: a four-week randomized comparison.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart rate variability biofeedback (HRVB) is increasingly examined as an adjunctive method for reducing psychological symptoms. Standard protocols involve identifying each participant's resonance frequency (RF); however, it remains unclear whether this individualized calibration offers advantages over training at a fixed breathing rate of 0.1 Hz. We conducted a randomized trial with three groups (RF, 0.1 Hz, Control) to compare the effectiveness of a four-week HRVB intervention using an individually determined RF versus a fixed breathing frequency of 0.1 Hz. Participants (N = 88) completed pre- and post-intervention assessments of perceived stress, anxiety, depressive symptoms (DASS-21), and resting HRV. Both HRVB groups showed significant reductions in stress, anxiety, and depressive symptoms relative to the control group, with no meaningful differences between them. Bayesian analysis provided anecdotal evidence favoring the null hypothesis of no difference between groups. The intervention did not produce significant changes in resting HRV. The present study does not permit firm conclusions regarding whether breathing at the RF confers additional benefits over breathing at a fixed rate of 0.1 Hz or whether the two approaches differ in effectiveness. Future studies aimed at detecting small differences between these approaches should include larger samples.Trial registration: The study was retrospectively registered at isrctn.com (Identifier ISRCTN17808563 date of first registration 20/01/2026, https//doi.org/10.1186/ISRCTN17808563). The full trial protocol and statistical analysis plan can be accessed via the registry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.